Ligand Pharmaceuticals Statistics
Total Valuation
REFR has a market cap or net worth of $51.48 million. The enterprise value is $51.44 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
REFR has 33.65 million shares outstanding. The number of shares has increased by 0.23% in one year.
| Current Share Class | 33.65M |
| Shares Outstanding | 33.65M |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | +19.45% |
| Owned by Insiders (%) | 9.34% |
| Owned by Institutions (%) | 16.24% |
| Float | 28.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 42.05 |
| Forward PS | n/a |
| PB Ratio | 28.63 |
| P/TBV Ratio | 28.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 42.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.04, with a Debt / Equity ratio of 0.69.
| Current Ratio | 7.04 |
| Quick Ratio | 6.46 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -73.36% and return on invested capital (ROIC) is -38.62%.
| Return on Equity (ROE) | -73.36% |
| Return on Assets (ROA) | -36.45% |
| Return on Invested Capital (ROIC) | -38.62% |
| Return on Capital Employed (ROCE) | -66.05% |
| Revenue Per Employee | $203,707 |
| Profits Per Employee | -$292,712 |
| Employee Count | 6 |
| Asset Turnover | 0.37 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.25% in the last 52 weeks. The beta is 0.09, so REFR's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -25.25% |
| 50-Day Moving Average | 1.73 |
| 200-Day Moving Average | 1.60 |
| Relative Strength Index (RSI) | 40.11 |
| Average Volume (20 Days) | 41,293 |
Short Selling Information
The latest short interest is 294,630, so 0.88% of the outstanding shares have been sold short.
| Short Interest | 294,630 |
| Short Previous Month | 300,889 |
| Short % of Shares Out | 0.88% |
| Short % of Float | 1.03% |
| Short Ratio (days to cover) | 9.75 |
Income Statement
In the last 12 months, REFR had revenue of $1.22 million and -$1.76 million in losses. Loss per share was -$0.05.
| Revenue | 1.22M |
| Gross Profit | -1.24M |
| Operating Income | -1.91M |
| Pretax Income | -1.05M |
| Net Income | -1.76M |
| EBITDA | -1.89M |
| EBIT | -1.91M |
| Loss Per Share | -$0.05 |
Full Income StatementBalance Sheet
The company has $1.27 million in cash and $1.23 million in debt, giving a net cash position of $41,914 or $0.00 per share.
| Cash & Cash Equivalents | 1.27M |
| Total Debt | 1.23M |
| Net Cash | 41,914 |
| Net Cash Per Share | $0.00 |
| Equity (Book Value) | 1.80M |
| Book Value Per Share | 0.05 |
| Working Capital | 1.69M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$930,548 and capital expenditures -$1,678, giving a free cash flow of -$932,226.
| Operating Cash Flow | -930,548 |
| Capital Expenditures | -1,678 |
| Free Cash Flow | -932,226 |
| FCF Per Share | -$0.03 |
Full Cash Flow StatementMargins
Gross margin is -101.07%, with operating and profit margins of -156.33% and -143.69%.
| Gross Margin | -101.07% |
| Operating Margin | -156.33% |
| Pretax Margin | -143.69% |
| Profit Margin | -143.69% |
| EBITDA Margin | -154.74% |
| EBIT Margin | -156.33% |
| FCF Margin | n/a |
